文献速递流行病学与生物统计基础与转化研究

2型糖尿病缓解定义在研究中的异质性:系统范围综述

Defining remission of type 2 diabetes in research studies: A systematic scoping review.
PubMed 文献 · PLoS Med · 2020-10-28

该系统范围综述检索2009年9月至2020年7月四个数据库,纳入178项研究(165项观察性、13项干预性),提取266个缓解定义,其中96个独特。结果显示定义存在显著异质性,仅45%引用2009年报告,93%要求无降糖治疗,87%指定血糖阈值,39%定义时间。结论强调需统一、明确的缓解定义。

要点

  • 2型糖尿病缓解定义在研究间高度异质,共识别96个独特定义。
  • 最常用血糖阈值为HbA1c<42 mmol/mol(6.0%),见于20%的定义。
  • 仅39%的定义包含时间维度,提示持续时间常被忽略。

核心结论

  • 2009年以来发表的2型糖尿病缓解研究定义存在显著异质性,部分反映2009年报告的模糊性。
  • 未来共识定义应包含明确的血糖阈值并强调持续时间。
  • 在达成国际共识前,研究应清晰定义缓解的全部三个组分。

研究设计与样本

  • 系统范围综述,检索MEDLINE、EMBASE、Cochrane Library和CINAHL四个数据库。
  • 纳入2009年9月1日至2020年7月18日发表的英文研究,样本量至少100例2型糖尿病成人。
  • 共筛选8966条标题/摘要,最终纳入来自33个国家的178项研究(165项观察性、13项干预性)。

主要发现

  • 共提取266个缓解定义,其中96个为独特定义,121个(45%)引用了2009年报告。
  • 247个(93%)定义要求无降糖治疗,232个(87%)定义指定了数值血糖阈值。
  • 最常用阈值为HbA1c<42 mmol/mol(6.0%),见于47个(20%)定义。
  • 104个(39%)定义将时间定义为持续时间,时间常被省略。

关键数值与推荐

  • 2009年报告建议缓解需满足三个组分:无降糖治疗、正常血糖、持续时间≥1年。
  • 最常用血糖阈值:HbA1c<42 mmol/mol(6.0%),见于20%的定义。
  • 93%的定义要求无降糖治疗,87%指定血糖阈值,39%定义时间。

临床怎么用

  • 临床解读2型糖尿病缓解研究时需注意定义异质性。
  • 描述缓解时应明确报告无降糖治疗、血糖阈值和持续时间三个组分。
  • 等待国际共识定义以统一研究 outcome 和临床沟通。

局限性

  • 仅纳入英文发表且样本量超过100的研究。
  • 未检索灰色文献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Remission has been identified as a top priority by people with type 2 diabetes. Remission is commonly used as an outcome in research studies; however, a widely accepted definition of remission of type 2 diabetes is lacking. A report on defining remission was published (but not formally endorsed) in Diabetes Care, an American Diabetes Association (ADA) journal. This Diabetes Care report remains widely used. It was the first to suggest 3 components necessary to define the presence of remission: (1) absence of glucose-lowering therapy (GLT); (2) normoglycaemia; and (3) for duration ≥1 year. Our aim is to systematically review how remission of type 2 diabetes has been defined by observational and interventional studies since publication of the 2009 report. METHODS AND FINDINGS: Four databases (MEDLINE, EMBASE, Cochrane Library, and CINAHL) were searched for studies published from 1 September 2009 to 18 July 2020 involving at least 100 participants with type 2 diabetes in their remission analysis, which examined an outcome of type 2 diabetes remission in adults ≥18 years and which had been published in English since 2009. Remission definitions were extracted and categorised by glucose-lowering therapy, glycaemic thresholds, and duration. A total of 8,966 titles/abstracts were screened, and 178 studies (165 observational and 13 interventional) from 33 countries were included. These contributed 266 definitions, of which 96 were unique. The 2009 report was referenced in 121 (45%) definitions. In total, 247 (93%) definitions required the absence of GLT, and 232 (87%) definitions specified numeric glycaemic thresholds. The most frequently used threshold was HbA1c<42 mmol/mol (6.0%) in 47 (20%) definitions. Time was frequently omitted. In this study, a total of 104 (39%) definitions defined time as a duration. The main limitations of this systematic review lie in the restriction to published studies written in English with sample sizes of over 100. Grey literature was not included in the search. CONCLUSIONS: We found that there is substantial heterogeneity in the definition of type 2 diabetes remission in research studies published since 2009, at least partly reflecting ambiguity in the 2009 report. This complicates interpretation of previous research on remission of type 2 diabetes and the implications for people with type 2 diabetes. Any new consensus definition of remission should include unambiguous glycaemic thresholds and emphasise duration. Until an international consensus is reached, studies describing remission should clearly define all 3 components of remission. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42019144619.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Captieux M, Prigge R, Wild S, et al. Defining remission of type 2 diabetes in research studies: A systematic scoping review. PLoS Med. 2020. PMID: 33112845. doi:10.1371/journal.pmed.1003396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。